Skip to content

Bullish Market

Analysts Are Bullish On These 2 Biotech Stocks

“2020 will be remembered as the year of the biotech sector,” declares the author of today’s article, who proceeds to highlight two biotech stocks that Morgan Stanley is bullish on – and which have also earned “Strong Buy” consensus ratings from the analyst community at large. For these two biotech stocks with significant upside potential, CLICK HERE.

Ahead Of Q1 Earnings, Goldman Sachs Is Bullish On These 4 Biotech Stocks

With all the attention the top-performing health care sector, and biopharmaceutical stocks in particular, are receiving, which biotech stocks are worth a look ahead of their first-quarter earnings reports? Analysts at Goldman Sachs have identified four that they are bullish on, and today’s article notes that “While their shares only suited for aggressive growth accounts with a high-risk profile, none… 

CLICK HERE »Ahead Of Q1 Earnings, Goldman Sachs Is Bullish On These 4 Biotech Stocks